ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 135 filers reported holding ANI PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $248 | -99.9% | 4,280 | -20.9% | 0.02% | -10.7% |
Q4 2021 | $250,000 | +3.3% | 5,410 | +30.2% | 0.03% | -22.2% |
Q1 2018 | $242,000 | -49.5% | 4,155 | -44.2% | 0.04% | -57.6% |
Q4 2017 | $479,000 | +128.1% | 7,442 | +65.9% | 0.08% | +112.5% |
Q2 2017 | $210,000 | – | 4,485 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 200,000 | $13,270,000 | 21.02% |
Healthcare Value Capital, LLC | 50,000 | $3,318,000 | 5.26% |
Consonance Capital Management LP | 653,258 | $43,344,000 | 4.17% |
1492 Capital Management LLC | 34,500 | $2,289,000 | 1.87% |
JW Asset Management, LLC | 29,722 | $1,972,000 | 1.36% |
FRANKLIN STREET ADVISORS INC /NC | 29,000 | $1,924,000 | 0.35% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 55,705 | $3,696,000 | 0.27% |
Ativo Capital Management LLC | 15,805 | $1,049,000 | 0.24% |
DIKER MANAGEMENT LLC | 9,810 | $651,000 | 0.23% |
CASTLEARK MANAGEMENT LLC | 100,615 | $6,676,000 | 0.20% |